Real-world Effectiveness of 2-dose SARS-CoV-2 Vaccination in Kidney Transplant Recipients
Abstract
The humoral response to two doses of SARS-CoV-2 (Covid-19) vaccine among transplant recipients is inferior to immunocompetent individuals.1 Data on the ‘real-world’ effectiveness of vaccination in kidney transplant recipients [KTRs] are lacking. We performed a cohort study to investigate the impact of vaccination on Covid-19 infection and outcomes in our kidney transplant program.
Related articles
Related articles are currently not available for this article.